Here are five things to know about the transaction and the company’s stock:
• The stock was sold at an average price of $37.84, for a total value of $1.45 million.
• Mr. Lavigne now directly owns 802,796 shares of LDR’s stock, valued at approximately $30.37 million.
• The stock currently has an average rating of “buy” and a consensus target price of $41.52.
• LDR has a 52-week low of $21.70 and a 52-week high of $40.428.
• The company’s market cap is $1.008 billion.
More articles on devices:
Medtronic is headed for strong 2015 — 8 reasons why
Bacterin heads to government medical facilities with Spartan Medical agreement
Zimmer shares drop by 3.36%: 5 quick notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
